Post by
Guytorule on Aug 19, 2024 8:57am
News...PD001 gets approval!!
Subsidiary "Sairiyo" gets Australian approval to commence trials for their drug PD001 phase 1 for responsive cancers and infectious deceases including Covid 19. Then applications to FDA for phase 2 and 3...Good news...now we wait for their KETARX product FINAL APPROVAL by FDA with its goal date of October 29th around the corner..
Comment by
Guytorule on Aug 19, 2024 10:54am
Buying opportunity for PharmaDrug (PHRX) listed on CSE company that owns the 51% and may be acquired by PharmaTher...which in it self waiting for their FDA approval very soon for Ketrax . Both these companies are buying opportunities..its a marriage thats needs to take place here with both companies in my opinion..all happenning soon. Good luck, ground floor investment..with massive upside..